Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Oramed Pharmaceuticals Inc
ORMPCurrent price
2.39 USD
-0.02 USD (-0.83%)
Last closed
2.39 USD
Company
www.oramed.com
ISIN
US68403P2039
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
94 584 080 USD
Yield for 12 month
-18.15 %
1Y
3Y
5Y
10Y
15Y
ORMP
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules for delivery of polypeptides. The company's product portfolio includes ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes, as well as in phase II clinical trial for the treatment of non-alcoholic steatohepatitis; and ORA-D-013-1 and ORA-D-013-2, which have completed phase II clinical trial for the treatment of type 2 diabetes. It has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York. Address: 1185 Avenue of the Americas, New York, NY, United States, 10036
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
3.25 USDP/E ratio
4.55Dividend Yield
–Current Year
+1 340 000 USD
Last Year
+2 703 000 USD
Current Quarter
–
Last Quarter
–
Current Year
+1 340 000 USD
Last Year
+2 703 000 USD
Current Quarter
–
Last Quarter
–
Key Figures ORMP
1 year
3 years
5 years
10 years
EBITDA
-12 848 000 USD
Operating Margin TTM
Price to Earnings
4.55
Return On Assets TTM
-4.12 %
PEG Ratio
–
Return On Equity TTM
2.89 %
Wall Street Target Price
3.25 USD
Revenue TTM
–
Book Value
3.89 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100.00 %
Dividend Yield
–
Gross Profit TTM
2 703 000 USD
Earnings per share
0.51 USD
Diluted Eps TTM
0.51 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ORMP
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History ORMP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:12
Payout Ratio
–
Last Split Date
23.01.2013
Stock Valuation ORMP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
4.55
Forward PE
–
Enterprise Value Revenue
2.86
Price Sales TTM
141.54
Enterprise Value EBITDA
0.52
Price Book MRQ
0.64
Financials ORMP
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ORMP
For 52 weeks
2.00 USD
3.67 USD
50 Day MA
2.38 USD
Shares Short Prior Month
313 896
200 Day MA
2.53 USD
Short Ratio
3.80
Shares Short
299 511
Short Percent
0.81 %
BeatStart